Elimination rates of dioxin congeners in former chlorophenol workers from Midland, Michigan

Environmental Health Perspectives

Volumn 121, Issue 1, 2013, Pages 39-45

  Aylward, Lesa L ^a   Collins, James J ^b   Bodner, Kenneth M ^b   Wilken, Michael ^b   Bodnar, Catherine M ^b  

^a LLP   (United States)

^b DOW CHEMICAL COMPANY   (United States)

Author keywords

Dioxin; Occupational exposure; Toxicokinetics

Indexed keywords

2, 3, 7, 8 TETRACHLORODIBENZO PARA DIOXIN; CHLOROPHENOL; DIOXIN; LIVER ENZYME; POLYCHLORINATED BIPHENYL; POLYCHLORINATED DIBENZODIOXIN; POLYCHLORINATED DIBENZOFURAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CHLORACNE; DATA COLLECTION METHOD; DRUG ELIMINATION; ENVIRONMENTAL EXPOSURE; HALF LIFE TIME; HUMAN; INFORMATION PROCESSING; LIPID BLOOD LEVEL; MEDICAL RECORD; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; TOXICOKINETICS; WORKER;

CHLOROPHENOLS; DIOXINS; ENVIRONMENTAL EXPOSURE; MICHIGAN; OCCUPATIONAL EXPOSURE;

EID: 84872088253     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1205544     Document Type: Article

References (28)

1. Aylward LL, Brunet RC, Carrier G, Hays SM, Cushing CA, Needham LL, et al. 2005. Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort. J Expo Anal Environ Epidemiol 15(1):51-65.
2. Bartell SM. 2012. Bias in half-life estimates using log concentration regression in the presence of background exposures, and potential solutions. J Expo Sci Environ Epidemiol 22(3):299-303.
3. Bond GG, McLaren EA, Lipps TE, Cook RR. 1990. Effect of reclassification of chloracne cases [Letter]. J Occup Med 32(5):423.
4. Centers for Disease Control and Prevention. 2009. Fourth National Report on Human Exposure to Environmental Chemicals. Available: http://www.cdc.gov/exposurereport/ [accessed 5 January 2010].
5. Charlier C, Desaive C, Plomteux G. 2002. Human exposure to endocrine disrupters: consequences of gastroplasty on plasma concentration of toxic pollutants. Int J Obes Relat Metab Disord 26(11):1465-1468.
6. Chevrier J, Dewailly É, Ayotte P, Mauriège P, Després JP, Tremblay A. 2000. Body weight loss increases plasma and adipose tissue concentrations of potentially toxic pollutants in obese individuals. Int J Obes Relat Metab Disord 24(10):1272-1278.
7. Collins JJ, Bodner K, Aylward LL, Wilken M, Bodnar CM. 2009a. Mortality rates among trichlorophenol workers with exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am J Epidemiol 170(4):501-506.
8. Collins JJ, Bodner K, Aylward LL, Wilken M, Swaen G, Budinsky R, et al. 2009b. Mortality rates among workers exposed to dioxins in the manufacture of pentachlorophenol. J Occup Environ Med 51(10):1212-1219.
9. Collins JJ, Budinsky RA, Burns CJ, Lamparski LL, Carson ML, Martin GD, et al. 2006. Serum dioxin levels in former chlorophenol workers. J Expo Sci Environ Epidemiol 16(1):76-84.
10. Deurenberg P, Weststrate JA, Seidell JC. 1991. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr 65(2):105-114.
11. Emond C, Birnbaum LS, DeVito MJ. 2006. Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD. Environ Health Perspect 114:1394-1400.
12. Flesch-Janys D, Becher H, Gurn P, Jung D, Konietzko J, Manz A, et al. 1996. Elimination of polychlorinated dibenzo-p-dioxins and dibenzofurans in occupationally exposed persons. J Toxicol Environ Health 47(4):363-378.
13. Hue O, Marcotte J, Berrigan F, Simoneau M, Dore J, Marceau P, et al. 2006. Increased plasma levels of toxic pollutants accompanying weight loss induced by hypocaloric diet or by bariatric surgery. Obes Surg 16(9):1145-1154.
14. Imbeault P, Chevrier J, Dewailly É, Ayotte P, Després JP, Tremblay A, et al. 2001. Increase in plasma pollutant levels in response to weight loss in humans is related to in vitro subcutaneous adipocyte basal lipolysis. Int J Obes Relat Metab Disord 25(11):1585-1591.
15. Lorber M, Huwe J, Rawn D. 2010. An update to estimates of intake of dioxin-like compounds for the general population of the United States. Organohalogen Compounds 72:316-319.
16. Lorber M, Patterson D, Huwe J, Kahn H. 2009. Evaluation of background exposures of Americans to dioxin-like compounds in the 1990s and the 2000s. Chemosphere 77(5):640-651.
17. Milbrath MO, Wenger Y, Chang CW, Emond C, Garabrant D, Gillespie BW, et al. 2009. Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age, body fat, smoking status, and breast-feeding. Environ Health Perspect 117:417-425.
18. Patterson DG Jr, Wong LY, Turner WE, Caudill SP, Dipietro ES, McClure PC, et al. 2009. Levels in the U.S. population of those persistent organic pollutants (2003-2004) included in the Stockholm Convention or in other long range transboundary air pollution agreements. Environ Sci Technol 43(4):1211-1218.
19. 3 concentration, and resting metabolic rate. Toxicol Sci 67(1):46-51.
20. Ritter R, Scheringer M, MacLeod M, Moeckel C, Jones KC, Hungerbuhler K. 2011. Intrinsic human elimination half-lives of polychlorinated biphenyls derived from the temporal evolution of cross-sectional biomonitoring data from the United Kingdom. Environ Health Perspect 119:225-231.
21. Ritter R, Scheringer M, MacLeod M, Schenker U, Hungerbuhler K. 2009. A multi-individual pharmacokinetic model framework for interpreting time trends of persistent chemicals in human populations: application to a postban situation. Environ Health Perspect 117:1280-1286.
22. Rohde S, Moser GA, Papke O, McLachlan MS. 1999. Clearance of PCDD/Fs via the gastrointestinal tract in occupationally exposed persons. Chemosphere 38(14):3397-3410.
23. Scott LL, Unice KM, Scott P, Nguyen LM, Haws LC, Harris M, et al. 2008. Addendum to: evaluation of PCDD/F and dioxin-like PCB serum concentration data from the 2001-2002 National Health and Nutrition Examination Survey of the United States population. J Expo Sci Environ Epidemiol 18(5):524-532.
24. U.S. Environmental Protection Agency. 2012. EPA's Reanalysis of Key Issues Related to Dioxin Toxicity and Response to NAS Comments, Volume 1 (CAS No. 1746-01-6) in Support of Summary Information on the Integrated Risk Information System (IRIS). EPA/600/R-10/038F. Available: http://www.epa.gov/iris/supdocs/dioxinv1sup.pdf [accessed 27 November 2012].
25. Van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, Feeley M, et al. 2006. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci 93(2):223-241.
26. van der Molen GW, Kooijman SA, Michalek JE, Slob W. 1998. The estimation of elimination rates of persistent compounds: a re-analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin levels in Vietnam veterans. Chemosphere 37(9-12):1833-1844.
27. Walford RL, Mock D, MacCallum T, Laseter JL. 1999. Physiologic changes in humans subjected to severe, selective calorie restriction for two years in Biosphere 2: health, aging, and toxicological perspectives. Toxicol Sci 52(2 suppl):61-65.
28. Wolfe WH, Michalek JE, Miner JC, Pirkle JL, Caudill SP, Patterson DG Jr, et al. 1994. Determinants of TCDD half-life in veterans of operation ranch hand. J Toxicol Environ Health 41(4):481-488.